The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Ubiquitin is conjugated with amino-terminally processed tau in paired helical filaments
Abstract
We have investigated ubiquitinated paired helical filaments, which produce a proteinaceous smear in SDS-polyacrylamide gel electrophoresis and immunoblotting. The smear consisted largely of the carboxy-terminal portion of tau and ubiquitin. The ubiquitin-targeted protein was identified as tau in paired helical filaments, and the conjugation sites were localized to the microtubule-binding region. Most ubiquitin in paired helical filaments occurred as a monoubiquitinated form, and only a small proportion of ubiquitin formed multiubiquitin chains. There was a ubiquitin-negative smear, in which tau was much less processed in the amino-terminal portion. This strongly suggests that the amino-terminal processing of tau in paired helical filaments precedes its ubiquitination.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Accumulation of ubiquitin-conjugated tau at Lys254, 257, 290, 311, 317 and 353 has been identified in PHF from AD brain and in an AD mouse model [161, 163, 164].”
From Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer’s disease (2020) · cites this paper as [163]
In the citing paper
“Therefore, ubiquitination plays an important role in maintaining a pool of cellular tau under physiological conditions.”
From Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer’s disease (2020) · cites this paper as [163]
Citations
Cites
The molecular pathology of Alzheimer's disease
Selkoe, D. J. (1991) · Neuron · doi:10.1016/0896-6273(91)90052-2 · Cited by 2,708
Goedert, M., Spillantini, M. G., Jakes, R., Rutherford, D., & Crowther, R. A. (1989) · Neuron · doi:10.1016/0896-6273(89)90210-9 · Cited by 2,492
A multiubiquitin chain is confined to specific lysine in a targeted short-lived protein
Chau, V., Tobias, J. W., Bachmair, A., Marriott, D., Ecker, D. J., Gonda, D. K., & Varshavsky, A. (1989) · Science · doi:10.1126/science.2538923 · Cited by 1,535
THE UBIQUITIN SYSTEM FOR PROTEIN DEGRADATION
Hershko, A., & Ciechanover, A. J. (1992) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.61.070192.003553 · Cited by 1,448
A68: a Major Subunit of Paired Helical Filaments and Derivatized Forms of Normal Tau
Lee, V. M.-Y., Balin, B. J., Otvos, L., & Trojanowski, J. Q. (1991) · Science · doi:10.1126/science.1899488 · Cited by 1,418
Goedert, M., Wischik, C. M., Crowther, R. A., Walker, J. E., & Klug, A. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.11.4051 · Cited by 1,134
Goedert, M., Spillantini, M. G., Potier, M. C., Ulrich, J., & Crowther, R. A. (1989) · The EMBO Journal · doi:10.1002/j.1460-2075.1989.tb03390.x · Cited by 1,037
Wischik, C. M., Novak, M., Thøgersen, H. C., Edwards, P. C., Runswick, M. J., Jakes, R., Walker, J. E., Milstein, C., Roth, M., & Klug, A. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.12.4506 · Cited by 939
Ubiquitin Is a Component of Paired Helical Filaments in Alzheimer's Disease
Mori, H., Kondo, J., & Ihara, Y. (1987) · Science · doi:10.1126/science.3029875 · Cited by 843
Self-citationGreenberg, S. G., & Davies, P. J. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.15.5827 · Cited by 735
Research works printed but not linked: 1
- DeCarli, 1992, Post-mortem regional neurofibrillary tangle densities but not senile plaque densities are related to regional cerebral metabolic rates for glucose during life in Alzheimer's disease patients, Neurodegeneration, 1, 113
Cited by
Sorted by citations
Items 101–200 of 333
Tau oligomerization: a role for tau aggregation intermediates linked to neurodegeneration
Sahara, N., Maeda, S., & Takashima, A. (2008) · Current Alzheimer Research · doi:10.2174/156720508786898442 · Cited by 99
Aggregation of Disordered Proteins Associated with Neurodegeneration
Tsoi, P. S., Quan, M. D., Ferreon, J. C., & Ferreon, A. C. M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043380 · Cited by 103
Parkin reverses intracellular β‐amyloid accumulation and its negative effects on proteasome function
Rosen, K. M., Moussa, C., Lee, H., Kumar, P., Kitada, T., Qin, G., Fu, Q., & Querfurth, H. W. (2009) · Journal of Neuroscience Research · doi:10.1002/jnr.22178 · Cited by 97
Ubiquitin and the Enigma of Intracellular Protein Degradation
Jennissen, H. P. (1995) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1995.tb20665.x · Cited by 92
Cell-based Models To Investigate Tau Aggregation
Lim, S., Haque, M. M., Kim, D., Kim, D. J., & Kim, Y. K. (2014) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2014.09.011 · Cited by 91
Broderick, T. L., Rasool, S., Li, R., Zhang, Y., Anderson, M., Al‐Nakkash, L., Plochocki, J. H., Geetha, T., & Babu, J. R. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21197337 · Cited by 89
Free radical theory of aging: Alzheimer’s disease pathogenesis
Harman, D. (1995) · AGE · doi:10.1007/bf02436085 · Cited by 87
Tauopathies: Deciphering Disease Mechanisms to Develop Effective Therapies
Silva, M. C., & Haggarty, S. J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21238948 · Cited by 89
Mykles, D. L. (1998) · International review of cytology · doi:10.1016/s0074-7696(08)62181-6 · Cited by 84
Sato, Y., Naito, Y., Grundke, I., Iqbal, K., & Endo, T. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02421-8 · Cited by 82
Ubiquitin, Autophagy and Neurodegenerative Diseases
Watanabe, Y., Taguchi, K., & Tanaka, M. (2020) · Cells · doi:10.3390/cells9092022 · Cited by 86
The ubiquitin protein catabolic disorders
Layfield, R., Alban, A., Mayer, R. J., & Lowe, J. S. (2001) · Neuropathology and Applied Neurobiology · doi:10.1046/j.1365-2990.2001.00335.x · Cited by 80
Johnson, G. V. W., & Bailey, C. D. C. (2002) · Journal of Alzheimer's Disease · doi:10.3233/jad-2002-4505 · Cited by 61
Takahashi, K., Ishida, M., Komano, H., & Takahashi, H. (2008) · Neuroscience Letters · doi:10.1016/j.neulet.2008.06.012 · Cited by 75
Goldbaum, O., & Richter‐Landsberg, C. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.1307-04.2004 · Cited by 75
The Role of Post-Translational Modifications on the Structure and Function of Tau Protein
Ye, H., Han, Y., Li, P., Su, Z., & Huang, Y. (2022) · Journal of Molecular Neuroscience · doi:10.1007/s12031-022-02002-0 · Cited by 76
Microtubule-associated protein tau is a substrate of ATP/Mg2+-dependent proteasome protease system
Zhang, J. Y., Liu, S. J., Li, H., & Wang, J. (2004) · Journal of Neural Transmission · doi:10.1007/s00702-004-0196-x · Cited by 75
Genetic risk factors in Alzheimer's disease.
Tilley, L. A., Morgan, K., & Kalsheker, N. A. (1998) · Molecular Pathology · doi:10.1136/mp.51.6.293 · Cited by 72
Adav, S. S., & Sze, S. K. (2016) · Molecular Brain · doi:10.1186/s13041-016-0272-9 · Cited by 75
The ubiquitin–proteasome system and neurodegenerative disorders
Layfield, R., Lowe, J. S., & Bedford, L. (2005) · Essays in Biochemistry · doi:10.1042/eb0410157 · Cited by 71
Hasegawa, M. (2016) · Biomolecules · doi:10.3390/biom6020024 · Cited by 75
Self-citationAcetylated tau in Alzheimer's disease: An instigator of synaptic dysfunction underlying memory loss
Tracy, T. E., & Gan, L. (2017) · BioEssays · doi:10.1002/bies.201600224 · Cited by 72
Mechanism of neurofibrillary degeneration in Alzheimer's disease
Iqbal, K., Alonso, A. D. C., Gong, C., Khatoon, S., Singh, T. J., & Grundke, I. (1994) · Molecular Neurobiology · doi:10.1007/bf02816111 · Cited by 72
Tau Protein Is Cross-Linked by Transglutaminase in P301L Tau Transgenic Mice
Halverson, R. A., Lewis, J. M., Frausto, S. F., Hutton, M., & Muma, N. A. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.3263-04.2005 · Cited by 69
Puangmalai, N., Sengupta, U., Bhatt, N., Gaikwad, S., Montalbano, M., Bhuyan, A., Garcia, S., McAllen, S., Sonawane, M., Jerez, C., et al. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.101766 · Cited by 68
Degradation or aggregation: the ramifications of post-translational modifications on tau
Park, S., Lee, J. H., Jeon, J. H., & Lee, M. J. (2018) · BMB Reports · doi:10.5483/bmbrep.2018.51.6.077 · Cited by 73
Molecular misreading: a new type of transcript mutation expressed during aging
van Leeuwen, F. W. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00151-2 · Cited by 68
Prion-like mechanisms and potential therapeutic targets in neurodegenerative disorders
Hasegawa, M., Nonaka, T., & Masuda‐Suzukake, M. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.11.010 · Cited by 71
Self-citationTargeting tau in Alzheimer's disease: from mechanisms to clinical therapy
Ye, J., Wan, H., Chen, S., & Liu, G. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.385847 · Cited by 74
Immunocytochemical characterization of glial fibrillary tangles in Alzheimer's disease brain.
Nishimura, M., Tomimoto, H., Suenaga, T., Namba, Y., Ikeda, K., Akiguchi, I., & Kimura, J. (1995) · Europe PMC (PubMed Central) · Cited by 65
PI31 Is an Adaptor Protein for Proteasome Transport in Axons and Required for Synaptic Development
Liu, K., Jones, S. K., Minis, A., Rodriguez, J., Molina, H., & Steller, H. (2019) · Developmental Cell · doi:10.1016/j.devcel.2019.06.009 · Cited by 66
Wischik, C. M., Edwards, P. C., Lai, R. Y. K., Gertz, H. N.-J., Xuereb, J. H., Paykel, E. S., Brayne, C., Huppert, F. A., Mukaetova-Ladinska, E. B., Mena, R., et al. (1995) · Neurobiology of Aging · doi:10.1016/0197-4580(95)97327-d · Cited by 65
Intracellular and Extracellular Roles for Tau in Neurodegenerative Disease
Hanger, D. P., Lau, D. H. W., Phillips, E. C., Bondulich, M. K., Guo, T., Woodward, B. W., Pooler, A. M., & Noble, W. J. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-132054 · Cited by 66
Kumar, P., Pradhan, K., Ramani, K., Ambasta, R. K., & Querfurth, H. W. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07588.x · Cited by 61
Ubiquitination and cysteine nitrosylation during aging and Alzheimer's disease
Riederer, I. M., Schiffrin, M., Kövari, E., Bouras, C., & Riederer, B. M. (2009) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2009.04.018 · Cited by 61
Miyasaka, T., Morishima-kawashima, M., Ravid, R., Heutink, P., van Swieten, J. V., Nagashima, K., & Ihara, Y. (2001) · American Journal of Pathology · doi:10.1016/s0002-9440(10)63979-x · Cited by 56
Self-citationFlach, K., Ramminger, E., Hilbrich, I., Arsalan-Werner, A., Albrecht, F., Herrmann, L., Goedert, M., Arendt, T., & Holzer, M. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.05.029 · Cited by 58
Shin, R., Ogino, K., Shimabuku, A., Taki, T., Nakashima, H., Ishihara, T., & Kitamoto, T. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0211-z · Cited by 57
Selective Deposition of Mutant Tau in the FTDP‐17 Brain Affected by the P301L Mutation
Miyasaka, T., Morishima-kawashima, M., Ravid, R., Kamphorst, W., Nagashima, K., & Ihara, Y. (2001) · Journal of Neuropathology and Experimental Neurology · doi:10.1093/jnen/60.9.872 · Cited by 58
Self-citationÖhrfelt, A., Johansson, P., Wallin, A., Andréasson, U., Zetterberg, H., Blennow, K., & Svensson, J. (2016) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000447239 · Cited by 59
Ainani, H., Bouchmaa, N., Ben Mrid, R., & El Fatimy, R. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106011 · Cited by 54
Tau Ubiquitination in Alzheimer's Disease
Li, L., Jiang, Y., Wang, J., Liu, R., & Wang, X. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2021.786353 · Cited by 57
Fergusson, J., Landon, M., Lowe, J. S., Dawson, S. P., Layfield, R., Hanger, D. P., & Mayer, R. J. (1996) · Neuroscience Letters · doi:10.1016/s0304-3940(96)13192-x · Cited by 54
Alzheimer neurofibrillary lesions: Molecular nature and potential roles of different components
Yen, S.-H. C., Liu, W.-K., Hall, F. L., Yan, S., Stern, D. M., & Dickson, D. W. (1995) · Neurobiology of Aging · doi:10.1016/0197-4580(95)00022-7 · Cited by 53
Watanabe, A., Hong, W., Dohmae, N., Takio, K., Morishima‐Kawashima, M., & Ihara, Y. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02611.x · Cited by 51
Self-citationKsiȩżak-Reding, H., Tracz, E., Yang, L., Dickson, D. W., Simon, M. N., & Wall, J. S. (1996) · Europe PMC (PubMed Central) · Cited by 51
Cytoskeletal mechanisms of neuronal degeneration
Brandt, R. (2001) · Cell and Tissue Research · doi:10.1007/s004410000334 · Cited by 52
PARKIN as a pathogenic gene for autosomal recessive juvenile parkinsonism
Shimizu, N., Asakawa, S., Minoshima, S., Kitada, T., Hattori, N., Matsumine, H., Yokochi, M., Yamamura, Y., & Mizuno, Y. (2000) · Springer eBooks · doi:10.1007/978-3-7091-6284-2_2 · Cited by 51
Molecular misreading of the ubiquitin B gene and hepatic mallory body formation
McPhaul, L., Wang, J., Hol, E. M., Sonnemans, M. A. F., Riley, N. E., Nguyen, V. T., Yuan, Q. X., Lue, Y., van Leeuwen, F. W., & French, S. W. (2002) · Gastroenterology · doi:10.1053/gast.2002.33629 · Cited by 50
Tau is not normally degraded by the proteasome
Feuillette, S., Blard, O., Lecourtois, M., Frébourg, T., Campion, D., & Dumanchin‐Njock, C. (2005) · Journal of Neuroscience Research · doi:10.1002/jnr.20414 · Cited by 48
Sequestosome 1/p62: across diseases
Geetha, T., Viswaprakash, N., Sycheva, M., & Babu, J. R. (2012) · Biomarkers · doi:10.3109/1354750x.2011.653986 · Cited by 48
Phosphorylated α‐synuclein in normal mouse brain
Hirai, Y., Fujita, S. C., Iwatsubo, T., & Hasegawa, M. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.07.046 · Cited by 45
Self-citationMisframed ubiquitin and impaired protein quality control: an early event in Alzheimer’s disease
Gentier, R. J. G., & van Leeuwen, F. W. (2015) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2015.00047 · Cited by 46
Parolini, F., Tira, R., Barracchia, C. G., Munari, F., Capaldi, S., D’Onofrio, M., & Assfalg, M. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2021.12.191 · Cited by 43
To target Tau pathologies, we must embrace and reconstruct their complexities
Limorenko, G., & Lashuel, H. A. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105536 · Cited by 41
Riley, N. E., Li, J., McPhaul, L., Bardag‐Gorce, F., Lue, Y., & French, S. W. (2003) · Experimental and Molecular Pathology · doi:10.1016/s0014-4800(02)00020-5 · Cited by 42
Immunoreactivity to Lys63-linked polyubiquitin is a feature of neurodegeneration
Paine, S., Bedford, L., Thorpe, J. R., Mayer, R. J., Cavey, J. R., Bajaj, N., Sheppard, P. W., Lowe, J., & Layfield, R. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.05.074 · Cited by 41
Caspase substrates and neurodegenerative diseases
Bulat, N., & Widmann, C. (2009) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2009.07.007 · Cited by 42
Lysosomal Fusion Dysfunction as a Unifying Hypothesis for Alzheimer's Disease Pathology
Funk, K. E., & Kuret, J. (2012) · International Journal of Alzheimer s Disease · doi:10.1155/2012/752894 · Cited by 41
Ye, Y., Klenerman, D., & Finley, D. J. (2019) · Journal of Molecular Biology · doi:10.1016/j.jmb.2019.08.021 · Cited by 39
Temperature and toxic Tau in Alzheimer's disease: new insights
Carrettiero, D. C., Santiago, F. E., Motzko-Soares, A. C. P., & Almeida, M. C. (2015) · Temperature · doi:10.1080/23328940.2015.1096438 · Cited by 41
Ubiquitin–proteasome pathway is compromised in CD45RO+ and CD45RA+ T lymphocyte subsets during aging
Ponnappan, U. (2002) · Experimental Gerontology · doi:10.1016/s0531-5565(01)00203-0 · Cited by 41
Visualization of Newly Deposited tau in Neurofibrillary Tangles and Neuropil Threads
Miyasaka, T., Watanabe, A., Saito, Y., Murayama, S., Mann, D. M. A., Yamazaki, M., Ravid, R., Morishima‐Kawashima, M., Nagashima, K., & Ihara, Y. (2005) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/01.jnen.0000173890.79058.1d · Cited by 45
Self-citationBrain Injury in the Context of Tauopathies
Abisambra, J. F., & Scheff, S. W. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-131019 · Cited by 38
Munari, F., Barracchia, C. G., Franchin, C., Parolini, F., Capaldi, S., Romeo, A., Bubacco, L., Assfalg, M., Arrigoni, G., & D’Onofrio, M. (2020) · Angewandte Chemie International Edition · doi:10.1002/anie.201916756 · Cited by 39
Failure of Ubiquitin Proteasome System: Risk for Neurodegenerative Diseases
Chen, Z., Geetha, T., & Babu, J. R. (2014) · Neurodegenerative Diseases · doi:10.1159/000367694 · Cited by 42
Wildgruber, R., Reil, G., Drews, O., Parlar, H., & Görg, A. (2002) · PROTEOMICS · doi:10.1002/1615-9861(200206)2:6 · Cited by 63
The propagation mechanisms of extracellular tau in Alzheimer’s disease
Wei, Y., Liu, M., & Wang, D. (2021) · Journal of Neurology · doi:10.1007/s00415-021-10573-y · Cited by 40
Recent Insights on Alzheimer’s Disease Originating from Yeast Models
Seynnaeve, D., Vecchio, M. D., Fruhmann, G., Verelst, J., Cools, M., Beckers, J., Mulvihill, D. P., Winderickx, J., & Franssens, V. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19071947 · Cited by 39
Pathogenic theories and intrathecal analysis of the sporadic form of Alzheimer’s disease
Torreilles, F., & Touchon, J. (2002) · Progress in Neurobiology · doi:10.1016/s0301-0082(01)00030-2 · Cited by 39
Hyun, D., Gray, D. A., Halliwell, B. B., & Jenner, P. G. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02493.x · Cited by 38
Lace, G., Wharton, S. B., & Ince, P. G. (2007) · Clinical Neuropathology · doi:10.5414/npp26043 · Cited by 37
Elevated Levels of τ and Ubiquitin in Brain and Cerebrospinal Fluid in Alzheimer’s Disease
Iqbal, K., & Grundke, I. (1997) · International Psychogeriatrics · doi:10.1017/s1041610297005024 · Cited by 39
Tau Abnormalities and the Potential Therapy in Alzheimer’s Disease
Almansoub, H. A. M. M., Tang, H. R., Wu, Y., Wang, D., Mahaman, Y. A. R., Wei, N., Almansob, Y. A. M., He, W., & Liu, D. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180868 · Cited by 39
Serotonin‐induced activation of the network for locomotion in adult spinal rats
Feraboli‐Lohnherr, D., Barthe, J., & Orsal, D. (1999) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19990101)55:1 · Cited by 106
The in vitro formation of recombinant τ polymers
Ledesma, M. D., Medina, M., & Ávila, J. (1996) · Molecular and Chemical Neuropathology · doi:10.1007/bf02815107 · Cited by 36
Semisynthetic Modification of Tau Protein with Di-Ubiquitin Chains for Aggregation Studies
Munari, F., Barracchia, C. G., Parolini, F., Tira, R., Bubacco, L., Assfalg, M., & D’Onofrio, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21124400 · Cited by 34
García‐Sierra, F., Jarero-Basulto, J. J., Krištofíková, Z., Majer, E., Binder, L. I., & Řı́pová, D. (2011) · Brain Pathology · doi:10.1111/j.1750-3639.2011.00525.x · Cited by 36
FoxO1 overexpression reduces Aβ production and tau phosphorylation in vitro
Zhang, W., Bai, S., Yang, J., Zhang, Y., Liu, Y., Nie, J., Meng, D., Shi, R., Yao, Z.-Y., Wang, M., et al. (2020) · Neuroscience Letters · doi:10.1016/j.neulet.2020.135322 · Cited by 31
Altered Levels and Isoforms of Tau and Nuclear Membrane Invaginations in Huntington’s Disease
Fernández‐Nogales, M., & Lucas, J. J. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00574 · Cited by 32
Examination of phosphorylated tau protein as a PHF-precursor at early stage alzheimer's disease
Lai, R. Y. K., Gertz, H. N.-J., Wischik, D., Xuereb, J. H., Mukaetova-Ladinska, E. B., Harrington, C. R., Edwards, P. C., Mena, R., Paykel, E. S., Brayne, C., et al. (1995) · Neurobiology of Aging · doi:10.1016/0197-4580(95)00041-c · Cited by 33
Nargeh, H., Aliabadi, F., Ajami, M., & Pazoki–Toroudi, H. (2021) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.1c00923 · Cited by 32
Delacourte, A. (1994) · Biomedicine & Pharmacotherapy · doi:10.1016/0753-3322(94)90174-0 · Cited by 33
Chapter 3 Ubiquitin and its role in neurodegeneration
Arnold, J., Dawson, S. P., Fergusson, J., Landon, M., Mayer, R. J., & Lowe, J. S. (1998) · Progress in brain research · doi:10.1016/s0079-6123(08)64004-2 · Cited by 32
Cente, M., Filipčík, P., Mandakova, S., Žilka, N., Krajciova, G., & Novák, M. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-1107 · Cited by 31
Księżak-Reding, H., Morgan, K., & Dickson, D. (1994) · Brain Research · doi:10.1016/0006-8993(94)91063-4 · Cited by 32
Therapeutic Strategies for Restoring Tau HomeostasisPreprint
Young, Z. T., Mok, S., & Gestwicki, J. E. (2017) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a024612 · Cited by 31
Post-Translational Modifications in Tau and Their Roles in Alzheimer's Pathology
Kalyaanamoorthy, S., Opare, S. K. A., Xu, X., Ganesan, A., & Rao, P. P. N. (2024) · Current Alzheimer Research · doi:10.2174/0115672050301407240408033046 · Cited by 32
Tau liquid–liquid phase separation: At the crossroads of tau physiology and tauopathy
Islam, M., Shen, F., Regmi, D., Petersen, K., Karim, M. R. U., & Du, D. (2024) · Journal of Cellular Physiology · doi:10.1002/jcp.30853 · Cited by 28
Caudle, W. M., Pan, S., Shi, M. Y., Quinn, T. J., Hoekstra, J. G., Beyer, R. P., Montine, T. J., & Zhang, J. (2008) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.200800043 · Cited by 26
Tamaoka, A., Mizusawa, H., Mori, H., & Shoji, S.-I. (1995) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(94)00275-s · Cited by 28
Sjödin, S., Hansson, O., Öhrfelt, A., Brinkmalm, G., Zetterberg, H., Brinkmalm, A., & Blennow, K. (2017) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.201700100 · Cited by 26
Therapeutic and diagnostic challenges for frontotemporal dementia
Dâ€TMAlton, S., & Lewis, J. M. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00204 · Cited by 26
Structural and functional characterization of 20S and 26S proteasomes from bovine brain
Piccinini, M., Tazartes, O., Mostert, M., Musso, A., DeMarchi, M., & RINAUDO, M. T. (2000) · Molecular Brain Research · doi:10.1016/s0169-328x(99)00337-x · Cited by 25
Nakayama, Y., Sakamoto, S., Tsuji, K., Ayaki, T., Tokunaga, F., & Ito, H. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2019.03.017 · Cited by 24
Yang, L.-S., & Księżak-Reding, H. (1998) · Acta Neuropathologica · doi:10.1007/s004010050928 · Cited by 23
Księżak-Reding, H., Shafit-Zagardo, B., & Shu, H.-Y. C. (1995) · Journal of Neuroscience Research · doi:10.1002/jnr.490410504 · Cited by 22
Dangerous Liaisons: Tau Interaction with Muscarinic Receptors
Wysocka, A., Pałasz, E., Steczkowska, M., & Niewiadomska, G. (2020) · Current Alzheimer Research · doi:10.2174/1567205017666200424134311 · Cited by 24
Yoshizaki, C., Tsukane, M., & Yamauchi, T. (2004) · Neuroscience Research · doi:10.1016/j.neures.2004.04.005 · Cited by 28
Immunohistochemical localization of ubiquitin cross‐reactive protein in human tissues
Lowe, J. S., McDermott, H., Loeb, K. R., Landon, M., Haas, A. L., & Mayer, R. J. (1995) · The Journal of Pathology · doi:10.1002/path.1711770210 · Cited by 23
Metadata
- Authors
- Morishima-Kawashima, M., Hasegawa, M., Takio, K., Suzuki, M., Titani, K., & Ihara, Y.
- Affiliations
- The University of Tokyo (JP)
- RIKEN (JP)
- Fujita Health University (JP)
- Venue
- Neuron
- Publisher
- Elsevier BV
- Published
- 1993-06
- Volume
- 10
- Issue
- 6
- Pages
- 1151-1160
- ISSN
- 0896-6273 (ISSN-L)
- OpenAlex
- W2012781495
- Cited by
- 332
- References
- 45
- Citations by year
- 2026: 9 · 2025: 11 · 2024: 6 · 2023: 9 · 2022: 9 · 2021: 10 · 2020: 14 · 2019: 9 · 2018: 8 · 2017: 7 · 2016: 13 · 2015: 9 · 2014: 10 · 2013: 3 · 2012: 10
- FWCI
- 10.43
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Neuron (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Ministry of Education, Culture, Sports, Science and Technology
- Ministry of Health and Welfare
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Keywords
- ubiquitin, tau protein, paired helical filaments, ubiquitination, microtubule-binding region, protein aggregation, Alzheimer's disease, ubiquitin chains, post-translational modification
- MeSH terms
- Amino Acid Sequence, Antibodies, Monoclonal, Chromatography, High Pressure Liquid, Electrophoresis, Polyacrylamide Gel, Humans, Microtubules, Molecular Sequence Data, Molecular Weight, Peptide Fragments, Peptide Mapping, Endopeptidases, Protein Binding, Mass Spectrometry, Ubiquitins, Neurofibrillary Tangles, tau Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review